Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Pratt

Showing results (551-560 of 553) with videos related to

Pageof 56
Sort By:
You have reached the last page of results.This site can display upto 553 results.
Chest|March 13, 2025
Low-Intensity vs Moderate-Intensity Anticoagulation for Venovenous Extracorporeal Membrane Oxygenation: The Strategies for Anticoagulation During Venovenous Extracorporeal Membrane Oxygenation Pilot TrialWhitney D Gannon, Elias H Pratt, Melissa A Vogelsong, et al.
BMJ Supportive & Palliative Care|September 27, 2022
Palliative care phenotypes among critically ill patients and family members: intensive care unit prospective cohort studyChristopher E Cox, Maren K Olsen, Alice Parish, et al.
British Journal of Cancer|August 14, 2014
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100B P Schneider, L Li, F Shen, et al.
Pageof 56

Showing results (551-560 of 553) with videos related to

Sort By:
Pageof 56
You have reached the last page of results.This site can display upto 553 results.
Chest|March 13, 2025
Low-Intensity vs Moderate-Intensity Anticoagulation for Venovenous Extracorporeal Membrane Oxygenation: The Strategies for Anticoagulation During Venovenous Extracorporeal Membrane Oxygenation Pilot TrialWhitney D Gannon, Elias H Pratt, Melissa A Vogelsong, et al.
BMJ Supportive & Palliative Care|September 27, 2022
Palliative care phenotypes among critically ill patients and family members: intensive care unit prospective cohort studyChristopher E Cox, Maren K Olsen, Alice Parish, et al.
British Journal of Cancer|August 14, 2014
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100B P Schneider, L Li, F Shen, et al.
Pageof 56